País: Israel
Língua: inglês
Origem: Ministry of Health
SPIRONOLACTONE
TEVA ISRAEL LTD
C03DA01
TABLETS
SPIRONOLACTONE 25 MG
PER OS
Required
TEVA ISRAEL LTD, ISRAEL
SPIRONOLACTONE
Edematous conditions: - congestive heart failure; - cirrosis of the liver accompanied by edema and/or ascites nephrotic syndrome. Essential hypertention. Primary hyperaldostronism. Hypokalemia.
2021-11-30
PATIENT LEAFLET IN ACCORDANCE WITH THE PHARMACISTS’ REGULATIONS (PREPARATIONS) – 1986 The medicine is dispensed with a doctor's prescription only SPIRONOLACTONE TEVA 25 MG SPIRONOLACTONE TEVA 100 MG TABLETS TABLETS COMPOSITION: COMPOSITION: Each tablet contains: Each tablet contains: Spironolactone 25 mg Spironolactone 100 mg For information about inactive ingredients see section 6 - “Additional information”. READ THE ENTIRE LEAFLET CAREFULLY BEFORE USING THE MEDICINE. This leaflet contains concise information about the medicine. If you have additional questions, refer to the doctor or the pharmacist. This medicine has been prescribed for your treatment. Do not pass it on to others. It may harm them even if it seems to you that their medical condition is similar. 1. WHAT IS THE MEDICINE INTENDED FOR? Treatment of congestive heart failure, cirrhosis of the liver accompanied by edema and ascites, lowering blood pressure, adrenal gland overactivity (hyperaldosteronism), hypokalemia (low levels of potassium in the blood). THERAPEUTIC CLASS: Spironolactone belongs to a group of medicines called potassium-sparing diuretics. 2. BEFORE USING THE MEDICINE Do not use this medicine if: • You are sensitive (allergic) to the active ingredient or to any of the other ingredients this medicine contains (see section 6 – “additional information”). • You suffer from urinary retention. • You suffer from a severe kidney disease. • You suffer from Addison’s disease (a disease characterized by a feeling of exhaustion, loss of weight and low blood pressure). • You suffer from hyperkalemia (excess potassium in the blood). • You are breastfeeding. • You are taking potassium-sparing diuretics or potassium supplements. • You are taking a medicine that contains the active ingredient eplerenone (administered to treat heart failure). • Do not use the medicine in children suffering from moderate to severe kidney disease. SPECIAL WARNINGS REGARDING THE USE OF THE MEDICINE BEFORE TREATMENT WITH SPIRONOLACTONE TEV Leia o documento completo